Lineage Cell Therapeutics Inc logo

Lineage Cell Therapeutics Inc

FRA:BT3 (USA)  
€ 0.97 (-7.21%) May 3
At Loss
P/B:
2.93
Market Cap:
€ 186.52M ($ 200.91M)
Enterprise V:
€ 156.19M ($ 168.25M)
Volume:
88.00
Avg Vol (2M):
96.00
Also Trade In:
Volume:
88.00
At Loss

Lineage Cell Therapeutics Inc Valuation Measures